Most uncomplicated urinary tract infections start in the bladder, and a fraction of them do get better without antibiotics, but the odds are not reassuring. A systematic review of studies tracking untreated or placebo-treated UTIs found that only about 42% of people reported improved symptoms within the first nine days, and up to 39% had not improved at all by six weeks. For the rest, an untreated bladder infection can climb into the kidneys, seed the bloodstream, or set the stage for recurring problems. The stakes depend heavily on who you are: a healthy young woman faces a different risk profile than a pregnant woman, an older adult, or a child.
Some Bladder Infections Do Resolve on Their Own
There is a real, documented phenomenon of uncomplicated lower UTIs clearing without antibiotics. A systematic review pooling data from randomized trials where some participants received placebo found that symptom improvement rose to roughly 42% over the first nine days and sat around 36% at six weeks. Progression to a kidney infection was rare in these trials, with only one placebo participant across two studies developing pyelonephritis. Adverse effects were low overall.1PubMed Central. Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review – Section: Results
Those numbers need context. The people in these studies were generally healthy, non-pregnant women with straightforward bladder infections and no complicating factors. Even so, roughly four in ten weren’t getting better after six weeks without treatment. And “uncomplicated” is doing a lot of work in that sentence. The moment you add pregnancy, diabetes, immune suppression, urinary tract abnormalities, or a catheter, the infection is reclassified as complicated, and the risk math shifts dramatically.1PubMed Central. Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review – Section: Results
Your body does have built-in defenses for clearing bacteria from the urinary tract. The innate immune system, particularly neutrophils and antimicrobial peptides produced by the bladder lining, is the primary defense. These responses can sometimes control and eliminate bacteria before they gain a real foothold, especially in the lower urinary tract where adaptive immune responses are more limited.2PubMed Central. The nature of immune responses to urinary tract infections – Section: Abstract But “sometimes” is the operative word. When those defenses fail, the infection has a clear path upward.
When the Infection Reaches the Kidneys
The most common serious consequence of an untreated lower UTI is pyelonephritis, a kidney infection. Bacteria that aren’t cleared from the bladder can travel up the ureters and colonize the kidney tissue. This triggers a robust inflammatory response: the body floods the area with immune cells to fight the bacteria, but the process itself causes collateral damage. The respiratory burst of phagocytosis, which kills bacteria through bursts of reactive oxygen, also damages renal tubules. On top of that, the infection can cause ischemia in parts of the kidney, and when blood flow returns, the reperfusion releases superoxide that harms tissue further.3American Journal of Kidney Diseases. Etiology and Pathophysiology of Pyelonephritis – Section: Abstract
The clinical picture of pyelonephritis is unmistakable when it hits full force: high fever, flank pain, nausea, and sometimes rigors. But the damage to the kidney can persist even after the infection resolves. If the infection is severe or repeated, it can lead to scarring and impaired kidney function over time.4PubMed Central. Uropathogen and host responses in pyelonephritis – Section: Abstract
In rare and extreme cases, an untreated kidney infection can progress to emphysematous pyelonephritis, a necrotizing infection where gas-forming organisms destroy kidney tissue. This is one of the most dangerous forms of urinary tract infection and carries high rates of kidney loss and death.5PubMed Central. Emphysematous pyelonephritis: classification, management, and prognosis – Section: Abstract Emphysematous pyelonephritis is most associated with people who have diabetes or other conditions that impair immune defenses, but its existence illustrates the outer edge of what an unchecked urinary infection can become.
The Special Risks During Pregnancy
Pregnancy changes the UTI calculus in two ways. First, the anatomical and hormonal changes of pregnancy make infections more likely and more likely to ascend to the kidneys. Second, the consequences extend to the baby. Even asymptomatic bacteriuria (bacteria in the urine with no symptoms) has been linked in pregnancy to preterm delivery, low birth weight, intrauterine growth restriction, and maternal complications including pre-eclampsia. Untreated acute pyelonephritis during pregnancy can lead to maternal sepsis.6PubMed Central. Urinary tract infections in pregnancy – Section: Abstract
A large retrospective study found that women diagnosed with a UTI during pregnancy had an elevated risk of delivering before 37 weeks, with adjusted risk ratios ranging from about 1.1 to 1.4 depending on how early the birth occurred. The risk was present regardless of whether the UTI was treated with antibiotics, though untreated infections carried a slightly higher risk ratio.7PubMed Central. Risk of Early Birth among Women with a Urinary Tract Infection: A Retrospective Cohort Study – Section: Results
A Swedish study quantified how sharply the preterm birth risk spikes in the days immediately following a UTI diagnosis. In the first week after a UTI diagnosed between weeks 22 and 27 of pregnancy, the adjusted hazard ratio for preterm birth was about 18.5 compared to women without a UTI. For infections diagnosed between weeks 28 and 31, the hazard ratio in the first week was roughly 13.5. Even three or more weeks after the UTI diagnosis, the risk remained elevated for early-pregnancy infections.8PubMed Central. Urinary tract infection during pregnancy and time relation to preterm birth-a Swedish observational study – Section: RESULTS This is why pregnant women are routinely screened for bacteria in their urine, even without symptoms, and why treatment is considered standard rather than optional.
Older Adults and Missed Warning Signs
In older adults, untreated UTIs pose a particular problem because the infections often don’t look like UTIs. A study of geriatric patients in a sub-acute ward found that typical urinary symptoms (burning, urgency, frequent urination) occurred in less than half of UTI cases. Fever showed up in only about 11% of cases. Instead, the infections presented with delirium in nearly 29% of cases, along with elevated rates of rapid heart rate and low blood pressure compared to patients without UTIs.9PubMed Central. Urinary tract infections in a geriatric sub-acute ward-health correlates and atypical presentations – Section: RESULTS
This matters for the “what happens if you don’t treat it” question because you can’t treat what you don’t recognize. An older person whose sudden confusion is attributed to aging or dementia rather than a UTI is, in effect, going untreated. And older adults are already classified as complicated hosts, meaning their infections carry higher baseline risks of progression.
Interestingly, though, a large English cohort study looking at elderly patients in primary care found no statistically significant increase in the odds of bloodstream infection within 60 days among those whose antibiotic treatment for a lower UTI was delayed or withheld, compared to those treated immediately. The adjusted odds ratio was 1.13, with confidence intervals crossing 1.0.10PubMed Central. Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: A cohort study using electronic health records in England – Section: Results The finding doesn’t mean delayed treatment is safe in all elderly patients, but it does suggest that for lower UTIs in older adults managed in primary care, the short-term risk of the bacteria reaching the bloodstream is lower than many people assume.
Children and the Risk of Permanent Kidney Scarring
In children, especially very young children, an untreated UTI raises concerns about lasting damage to still-developing kidneys. Acute pyelonephritis in children can cause renal scarring, and that scarring carries long-term consequences including later hypertension, proteinuria, and reduced kidney function.11PubMed Central. Renal scar formation after urinary tract infection in children – Section: Abstract Research on pyelonephritis has found that infections occurring in the first three years of life are especially likely to produce the kind of kidney damage that could eventually progress to end-stage renal disease.3American Journal of Kidney Diseases. Etiology and Pathophysiology of Pyelonephritis – Section: Abstract
A large electronic cohort study following Welsh children through primary and secondary care records found that children with UTIs had significantly higher odds of renal scarring by age seven compared to those without, with an adjusted odds ratio of about 4.6. The study also reported modestly elevated hazard ratios for hypertension and chronic kidney disease in the UTI group, though the confidence intervals for those outcomes were wide enough that the results were not statistically significant.12PubMed Central. Long-term consequences of urinary tract infection in childhood: an electronic population-based cohort study in Welsh primary and secondary care – Section: Results The scarring finding is robust; the downstream kidney and blood pressure consequences likely depend on severity and recurrence.
Why Taking Pain Relievers Instead of Antibiotics Falls Short
A common temptation when UTI symptoms hit is to manage the pain with anti-inflammatory drugs and hope things resolve. Several randomized trials have tested this directly, comparing NSAIDs alone against antibiotic treatment for uncomplicated lower UTIs. A Cochrane review summarizing these trials found that NSAIDs probably result in less symptom resolution in the short term, with a relative risk of about 0.67 compared to antibiotics. Women given NSAIDs alone experienced roughly an extra day of symptoms on average and were about three times more likely to need rescue antibiotics within a month.13PubMed Central. Non‐steroidal anti‐inflammatory drugs (NSAIDs) for treating uncomplicated urinary tract infection in non‐pregnant adult women
More concerning than the slower symptom relief was the complication rate. A meta-analysis found that the odds of developing an upper UTI complication (meaning the infection climbed to the kidneys) were about six and a half times higher in the NSAID-only group compared to those who received antibiotics. Women in the NSAID group were also nearly three times more likely to still have a positive urine culture at follow-up, meaning the bacteria persisted even when symptoms partly eased.14PubMed Central. Symptomatic treatment (using NSAIDS) versus antibiotics in uncomplicated lower urinary tract infection: a meta-analysis and systematic review of randomized controlled trials – Section: Results
These findings reinforce a key point: feeling better is not the same as being clear of infection. NSAIDs mask the pain while bacteria may continue multiplying or ascending. For someone who genuinely cannot access antibiotics quickly, short-term symptom management with NSAIDs isn’t unreasonable, but it’s not a substitute for actual treatment.
How Bacteria Hide Inside the Bladder
One of the more unsettling discoveries about UTIs is that the bacteria responsible, primarily certain strains of E. coli, don’t just float in the urine waiting to be flushed out. Research has shown that these bacteria can invade bladder lining cells and form biofilm-like structures called intracellular bacterial communities. These pods contain bacteria encased in a protective matrix, shielded by the bladder’s own uroplakin proteins. Inside these pods, bacteria are largely hidden from immune defenses and from antibiotics circulating in the urine.15PubMed. Intracellular bacterial biofilm-like pods in urinary tract infections
This mechanism helps explain why bladder infections recur so often. Even after symptoms resolve and urine cultures come back clean, bacteria can persist inside cells, re-emerging weeks or months later to cause a new episode. It also helps explain why some people experience recurrent UTIs that seem to come out of nowhere, without an obvious new exposure. The infection may never have fully left. This is one reason the “wait and see” approach to UTIs carries a hidden risk: what seems like a resolved infection might instead be a quiet reservoir waiting for the right conditions to flare again.
When Bacteria in the Urine Should Not Be Treated
Here’s a wrinkle that surprises many people: there are situations where bacteria are present in the urine, but treating them actually makes things worse. This is the case of asymptomatic bacteriuria in women with recurrent UTIs. Recent research has demonstrated that in young women prone to recurring infections, the bacteria present without symptoms may actually play a protective role, competing with more aggressive strains and preventing symptomatic episodes. Treating asymptomatic bacteriuria in this group has been linked to a higher occurrence of antibiotic-resistant bacteria, making future infections harder to treat.16PubMed Central. Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat – Section: Abstract
This is distinctly different from asymptomatic bacteriuria in pregnancy, where screening and treatment are standard because of the maternal and fetal risks described above. The distinction matters: the right answer to “should I treat this?” depends on the context. In a healthy young woman with no symptoms and a history of recurrent UTIs, a positive urine culture alone is not necessarily a reason to reach for antibiotics. In a pregnant woman or someone with a compromised immune system, it usually is.
What Recurrent Infections Do to the Kidneys Over Time
Beyond the acute risks, there’s growing evidence that repeated UTIs take a cumulative toll on kidney health and cardiovascular function. A comparative study of adult women found that those with recurrent UTIs had lower estimated kidney filtration rates, higher blood urea levels, and more frequent microalbuminuria (a marker of early kidney damage that showed up in about a third of the recurrent-UTI group compared to 8% of controls). The recurrent-UTI group also had higher blood pressure readings on average, and the association between recurrent infections and lower kidney function remained even after adjusting for age and other health factors.17European Journal of Cardiovascular Medicine. Effect of Recurrent Urinary Tract Infections on Renal Function Parameters and Blood Pressure Regulation in Adult Women: A Comparative Study – Section: RESULTS
This study doesn’t prove that recurrent UTIs cause kidney decline and elevated blood pressure on their own, since women with recurrent infections may share other risk factors. But the biological plausibility is clear: repeated bouts of infection and inflammation scar and damage kidney tissue over time, and impaired kidney function is a well-known driver of elevated blood pressure. The findings add weight to the argument that preventing and promptly treating UTIs is not just about comfort but about long-term organ health.
Antibiotic Resistance and the Reinfection Problem
One of the more nuanced concerns about UTI treatment, whether prompt or delayed, is antibiotic resistance. A large-scale study combining whole-genome sequencing of over a thousand bacterial isolates with machine-learning analysis of more than 140,000 urinary tract infections found something that reframes the resistance conversation. When resistance emerged after antibiotic treatment, it was usually not because the original bacteria evolved resistance. Instead, the patient was rapidly reinfected by a different strain that was already resistant to the prescribed drug.18PubMed Central. Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections
This finding has practical implications. It means the resistance problem is less about one antibiotic course “teaching” your bacteria to resist it and more about the ecological shuffle that happens when antibiotics clear your current infection, opening space for resistant strains already present in your body or environment to move in. The study also found that the emergence of resistance could be predicted and minimized at the individual patient level, which points toward a future where antibiotic choice is tailored more precisely to reduce reinfection risk.
For someone weighing whether to treat a UTI, the resistance question cuts both ways. Unnecessary antibiotic use (as in the case of asymptomatic bacteriuria in non-pregnant women) promotes resistant reinfection. But failing to treat a genuinely symptomatic infection, or delaying too long, raises the chance of complications that may ultimately require stronger, broader-spectrum antibiotics. The sweet spot is targeted treatment when symptoms and risk factors warrant it, not blanket prescribing for every positive culture and not cavalier avoidance when infection is genuinely present.
D-Mannose and Preventing Recurrence
For people looking for ways to reduce their UTI frequency without relying on repeated antibiotic courses, D-mannose has attracted attention. It’s a simple sugar that, after being taken orally, is excreted in the urine, where it can bind to the same receptor sites on bladder cells that E. coli use to attach. The idea is straightforward: if the bacteria can’t stick to the bladder wall, they get flushed out during urination.19PubMed Central. D‐mannose for preventing and treating urinary tract infections – Section: Abstract
Several clinical studies have reported that D-mannose can help prevent recurrent UTIs, though the evidence for using it to treat an active acute infection is still limited.20PubMed Central. Why d-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and Conclusions from a Non-Interventional Study – Section: Abstract D-mannose is generally well tolerated with minimal side effects, and it works through a fundamentally different mechanism than antibiotics, meaning it doesn’t contribute to resistance. The limitation is that it targets only E. coli strains that use mannose-binding adhesion proteins. UTIs caused by other organisms, or by E. coli strains with different adhesion strategies, won’t respond to it. Still, since E. coli is responsible for the majority of uncomplicated UTIs, D-mannose is a reasonable addition to a prevention strategy for people dealing with frequent recurrences.